Illumina is an American company that specialises in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. Established in 1998, Illumina provide a line of products and services that serve the sequencing, genotyping and gene expression markets. Their technology has significantly reduced the cost of sequencing a human genome and, as a result, they were named the “world’s smartest company” by MIT Technology Review in 2014. Illumina’s clients include research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies.